Provider
P60-17 2018 Renewal Changes Summary for Institutional Providers
Program effective Date: Nov 01, 2017
Documents & Forms Results
Displaying 3411 - 3420 of 3630 results
Provider
P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess
Program effective Date: Dec 13, 2016
Provider
P52-16 DHS Guidelines for Mental Health-Targeted Case Management Services for MHCP Subscribers
Program effective Date: Nov 04, 2016
Provider
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Program effective Date: Nov 06, 2017
Provider
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Program effective Date: Dec 20, 2016
Provider
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Program effective Date: Jun 05, 2017
Provider
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Oct 24, 2017
Provider
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Program effective Date: Jul 11, 2017
Provider
P62-16 EY Modifier for Platinum Blue Subscribers
Program effective Date: Dec 13, 2016
Provider
P32-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Kuvan
Program effective Date: Jul 27, 2016